Videos
The organization identifies, pilots and scales healthcare innovations through close collaboration with public- and private-sector partners, says Alexander Richter, executive director and head of the SciTech Innovation Hub at SciTech Scity.
Jim Roeder, CIO and VP of IT for Lakewood Health in Staples, Minn., says expert rural IT panelists at HIMSS26 will share cost effective approaches to handling limited resources, staffing and infrastructure needs and discuss regional collaboration.
The electrode technology is designed to improve neurological care for patients with motor issues and pain, using thin-film, flexible electrodes implanted on the brain. Dave Rosa, CEO of NeuroOne, explains.
VA Puget Sound Health Care System's X_Labs is pioneering 3D-printed bone grafts. Dr. Mark Zhang, acting assistant under secretary for health at the U.S. Department of Veterans Affairs, shows how.
Its 2026 Innovation Challenge is designed to attract technologies that can support the island's vision for digitally enabled, sustainable healthcare, says Teresa Cope, CEO of Manx Care.
Additionally, the company's nine AI-enabled drug discovery portfolio companies are making an impact in life sciences, says AION Labs CEO Mati Gill.
According to Emirates Health Services' H.E. Mubaraka Ibrahim, the UAE is using clinical and non-clinical AI tools across its facilities to give clinicians time back and to support precision medicine and healthier communities.
The chief information officer of the 25-bed New Mexico nonprofit describes how he's using AI to help with network defense, and how that's enabling gains in other areas. He also discusses plan for some clinical new applications of AI.
Concept Realisation's Nasser Massoud says GCC digital health success depends on patients trusting technology, regulators supporting innovation sans safety risks and insurers paying providers fairly for telehealth services.
Michael Abrams of Numerof & Associates explains the need for the U.S. Food and Drug Administration to move faster on healthcare artificial intelligence governance, and why its drug development validation process is a good model.